Please find all related articles below.
Many people are already embracing the possibilities of eHealth but what is preventing eHealth from becoming a widespread reality? And what could be the potential solutions?
The eHealth revolution has been a slow burner for many years but the advent of mobile and wearable technologies (from mHealth to smart watches), Big Data and the Internet of Things provide an array of new possibilities for eHealth as vast amounts of health data can in theory be (self-)generated, transmitted, stored and (...)
Partners of the ENS4Care project presented the final guidelines for the deployment of eHealth by nurses and social workers to policymakers on 8 December 2015 in the context of the European Innovation Summit,. The acceptance of eHealth by health and social care professionals is fundamental in order for it to be taken up successfully across Europe.
The project - ENS4Care
Over the last two years, the partners of the ENS4Care project, which also includes EPHA, have developed eHealth (...)
eHealth, mobile apps and digital medical services are sparking many hopes and concerns at the same time. The #Datacare debate held on 15 September 2015 at the European Parliament specifically explored the question, “What can data driven healthcare do for Europe?”
In our globalised, digital world, things are changing rapidly and technology is an inevitable, driving feature of innovation. In the future, health systems are likely to be permeated more and more by technology. Now is (...)
Public health is not just about human diseases, healthcare services or cross-border pandemics. Most of all, health is about people. Giving wider attention to the individual also fits perfectly with the European 2020 vision of ’smart, inclusive and sustainable’ growth for a healthier EU, as highlighted at a recent meeting on ’health literacy in Europe’ organised by STOA - European Parliament Science and Technology Options Assessment - on 1 July 2015.
People are used (...)
Unsurprisingly, mHealth was a hotly debated topic during the 2015 eHealth Week hosted by the Latvian Council Presidency. In addition to the official conference programme, where the mHealth summit uncovered some of the latest developments in this area, the European Commission also organised a stakeholder meeting including industry and civil society representatives to determine the appropriate level of regulation for mHealth at EU level.
European Health Commissioner Vytenis Andriukaitis (...)
Brussels, 11 May 2015 – The 2015 eHealth forum, organised under the auspices of the Latvian Presidency, will discuss the next steps regarding the further roll-out of eHealth in Europe. Mobile smartphone applications in particular have propelled eHealth to centre stage in recent years. As noted in the European Commission’s Green Paper on mobile Health (mHealth) (1), 100,000 health apps are already on the market and it is estimated that 50% of smartphone owners will be using them (...)
A new European Data in Health Research Alliance was launched in early December. This campaign, supported by a number of health organisations active across Europe and representing research, patient and public health concerns, was set up to demonstrate in the most tangible way that personal data in research is vital because it saves lives.
The Alliance was established by Cancer Research UK, the Medical Sciences Committee of Science Europe, European Patients’ Forum, the Federation of (...)
November 20014 - Despite the existence of various pro-public health guidelines, Mr. Juncker’s Commission Programme gives cause for concern.
The European Commission President Mr. Juncker and First Vice-President Mr. Timmermans outlined the draft list of key initiatives that constitute the Commission Work Programme (CWP), with an aim for it to be adopted in Strasbourg on December 16 after a discussion with the Members of the European Parliament. In a meantime, a number of political (...)
28 October 2014, Brussels – MEPs, patients and the European public health community are today asking President-elect Juncker to clarify whether medical devices and health technologies will remain in the directorate for health or not. Fears over patient safety remain as Mr Juncker has so far failed to publicly clarify his ambiguous statement (1) last week to the European Parliament.
Last week’s statement of the European Commission’s President-elect that the competence for (...)
Further to our Joint Letter of 16 September 2014 (1) , we are contacting you again to express our gratitude for your decision (2) to move the competence for medicines and pharmaceutical products back into the hands of the European Commissioner for Health. We firmly believe that this directorate is best placed to ensure a good balance between economic and public health objectives while promoting ‘smart, sustainable and inclusive’ growth for Europe.
28 October 2014, Brussels (...)